The risk of malignancy was increased in patients who underwent 2 or 3 lines of treatment compared to patients who underwent only 1 line of treatment.
Risk for malignancy was increased in patients who underwent 2 or 3 lines of treatment compared with patients who only underwent 1 line of treatment.